Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 1 10Phase 1/2 5Phase 3 4Phase NA 3Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Unknown 5Completed 5Active not recruiting 5Terminated 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 32CNS 28Lymphoid 23Thoracic 19Breast 18Genitourinary 17Head & Neck 16Dermatologic 15Other hematologic neoplasm 14Gynecologic 13Sarcoma 9Other solid neoplasm 8Tumor-Agnostic 6Plasma cell 6Endocrine 3NET 2Myeloid 2Other neoplasm 1Classical hematology 1

Conditions

Neuroendocrine Tumors 2von Hippel-Lindau Disease 1Multiple Endocrine Neoplasia Type 1 1Meningioma 1

Interventions

gallium Ga 68 dotatate 1Magnetic Resonance Spectroscopy 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × NET × Clear all
NCT03724409 2023-11-28

Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases

University of Iowa

Phase EARLY_PHASE1 Terminated
3 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03001349 2021-02-15

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSEndocrineNET

von Hippel-Lindau Disease, Meningioma, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡